NAVIGATE ESUS: Multicenter, Randomized, Double-Blind, Phase III Trial of Rivaroxaban vs. Aspirin for the Prevention of Recurrent Stroke and Systemic Embolism in Patients with Recent Embolic Stroke of Undetermined Source

NAVIGATE ESUS Asia Pacific

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)34-35
Number of pages2
JournalCerebrovascular Diseases
Volume40
Publication statusPublished - Oct 2015
EventAsia Pacific Stroke Conference 2015 Annual Conference of the Asia Pacific Stroke Organization (APSO) - Kuala Lumpur, Malaysia
Duration: 2 Oct 20154 Oct 2015

Cite this